R&D

Overview

AGM-331 AGM-130 AGM-380 AGM-290 AGM-212 AGM-217 AGM-260
Anti-Obesity peptide Drug AGM-217
AGM-217 which is a heterodimeric form acting as a specific agonist for both a GLP-1 receptor and Glucagon receptor improved the treatment with type 2 diabetes and obese models.

  • The administration of AGM-217 in obese mice increased body weight loss.

  • The administration of AGM-217 in obese mice increased body weight loss more than liraglutide.

  • The molecular mechanism of AGM-217 is enhanced thermogenesis inducing effects in brown adipose tissues.